Insider trading research with Taiwanese vaccine makers reveals broader issues
bernardblack, 02 July 2021
A survey of insider trading with Taiwan’s Covid-19 vaccine maker raised concerns about Taiwan’s fiscal oversight and involved President Tsai Ing-wen’s administration.
The Taipei-based Shilin District prosecutor’s office said Medigen Vaccine Biologics Corporation after the company’s stake jumped more than 20% in the days before announcing positive results for a phase II vaccine trial in June. He told the Financial Times that he was investigating. The prosecution refused to reveal the details of the investigation. Continue reading “Article: Insider trading research with Taiwanese vaccine makers reveals broader issues”
Alibaba shares jump after record $2.8bn anti-monopoly fine
Mark Sweney, 12 April 2021
Shares in Alibaba surged on Monday after the e-commerce company said that a record $2.8bn (£2bn) fine handed down by Chinese regulators marked the end of an investigation into anti-competitive practices at the company.
Top executives at the company, founded by the billionaire Jack Ma, told investors that while Chinese regulators continued a wider investigation into the sprawling conglomerates in the country’s tech industry, they believed the multibillion dollar fine announced at the weekend marked the end of the focus on Alibaba. The company is listed in Hong Kong and its shares climbed as much as 9% on the management’s comments. Continue reading “Article: Alibaba shares jump after record $2.8bn anti-monopoly fine”